A detailed history of Castleark Management LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 139,880 shares of CDNA stock, worth $3 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
139,880
Holding current value
$3 Million
% of portfolio
0.18%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $2.02 Million - $4.75 Million
139,880 New
139,880 $4.37 Million
Q4 2021

Feb 16, 2022

SELL
$41.2 - $73.6 $2.95 Million - $5.28 Million
-71,720 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.15 - $91.99 $4.24 Million - $6.6 Million
71,720 New
71,720 $4.55 Million
Q1 2021

May 14, 2021

SELL
$57.62 - $95.6 $11.5 Million - $19.1 Million
-199,897 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$41.43 - $77.09 $4.93 Million - $9.17 Million
-118,918 Reduced 37.3%
199,897 $14.5 Million
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $1.12 Million - $1.37 Million
36,118 Added 12.78%
318,815 $12.1 Million
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $5.36 Million - $10 Million
282,697 New
282,697 $10 Million
Q2 2019

Aug 13, 2019

SELL
$25.78 - $39.77 $5.05 Million - $7.8 Million
-196,005 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$22.09 - $39.21 $1.68 Million - $2.98 Million
-75,965 Reduced 27.93%
196,005 $6.18 Million
Q4 2018

Feb 12, 2019

BUY
$19.89 - $30.02 $1.27 Million - $1.91 Million
63,735 Added 30.61%
271,970 $6.84 Million
Q3 2018

Nov 15, 2018

BUY
$12.1 - $28.85 $2.52 Million - $6.01 Million
208,235 New
208,235 $6.01 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.